Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory lung disease that causes obstruction of airflow from the lungs.
Mesenchymal stem cell therapy for the treatment of COPD has been shown to have very positive effects on patients.
Stopping the progression of the disease, fighting inflammation and fibrosis, improving lung function, reducing the risk of death and oxygen dependence is possible with advances in regenerative medicine and stem cells.
At Stem Life Clinic, we have a treatment protocol with mesenchymal stem cells obtained from the umbilical cord (Wharton’s jelly) for the treatment of COPD. This treatment offers hope to patients to improve the quality of life and reduce the symptoms of COPD.
COPD is a lung disease that reduces airflow to the lungs, causing serious breathing problems. Also known as emphysema or chronic bronchitis, COPD is a disease that causes symptoms such as coughing (with or without sputum), wheezing, fatigue, and shortness of breath.
COPD is estimated to cause 3 million deaths each year around the world. It is a disease that has no cure and in which the affected people are at greater risk of suffering from other health problems.
Mesenchymal stem cells have the ability to differentiate into type II pneumocytes, which produce pulmonary surfactant that is released into the alveoli to combat respiratory diseases.
The effects of stem cells are the following: decrease inflammatory processes, increase growth factors, promote cell self-repair, improve lung function and the patient’s quality of life.
Mesenchymal stem cell therapy carries no risk of serious adverse reactions, infections, and may enhance medical treatment for COPD.
Mesenchymal stem cell therapy holds promise for the treatment of COPD and other chronic lung diseases, especially when administered early.
Chronic lung diseases are one of the main causes of mortality worldwide: asthma, COPD, pulmonary fibrosis, among others.
Unfortunately, there is no conventional treatment that stops the progression of these diseases, restores, reverses lung damage, or allows complete repair of lung function.
However, regenerative medicine with mesenchymal stem cell treatment offers hope for COPD patients to regain their quality of life.